These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 1978849)

  • 1. Glutathione S-transferase. Novel vaccine against Fasciola hepatica infection in sheep.
    Sexton JL; Milner AR; Panaccio M; Waddington J; Wijffels G; Chandler D; Thompson C; Wilson L; Spithill TW; Mitchell GF
    J Immunol; 1990 Dec; 145(11):3905-10. PubMed ID: 1978849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host responses during experimental infection with Fasciola gigantica or Fasciola hepatica in Merino sheep I. Comparative immunological and plasma biochemical changes during early infection.
    Raadsma HW; Kingsford NM; Suharyanta ; Spithill TW; Piedrafita D
    Vet Parasitol; 2007 Feb; 143(3-4):275-86. PubMed ID: 17069976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An attempt to vaccinate sheep against Fasciola hepatica using a juvenile fluke antigen sheep antibody complex.
    Sandeman RM; Howell MJ; Campbell NJ
    Res Vet Sci; 1980 Sep; 29(2):255-9. PubMed ID: 6110229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vaccine potential of inclusion bodies containing cysteine proteinase of Fasciola hepatica in calves and lambs experimentally challenged with metacercariae of the fluke.
    Wedrychowicz H; Kesik M; Kaliniak M; Kozak-Cieszczyk M; Jedlina-Panasiuk L; Jaros S; Plucienniczak A
    Vet Parasitol; 2007 Jun; 147(1-2):77-88. PubMed ID: 17481823
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The recombinant gut-associated M17 leucine aminopeptidase in combination with different adjuvants confers a high level of protection against Fasciola hepatica infection in sheep.
    Maggioli G; Acosta D; Silveira F; Rossi S; Giacaman S; Basika T; Gayo V; Rosadilla D; Roche L; Tort J; Carmona C
    Vaccine; 2011 Nov; 29(48):9057-63. PubMed ID: 21939713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Quil A adjuvant on the course of experimental Fasciola hepatica infection in sheep.
    Haçariz O; Sayers G; McCullough M; Garrett M; O'Donovan J; Mulcahy G
    Vaccine; 2009 Jan; 27(1):45-50. PubMed ID: 18977261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of humoral and cellular responses against glutathione S-transferases in Fasciola hepatica experimentally infected sheep.
    Moreau E; Chauvin A; Boulard C
    Vet Res; 1998; 29(6):585-91. PubMed ID: 9851016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune response of goats immunised with glutathione S-transferase and experimentally challenged with Fasciola hepatica.
    Buffoni L; Zafra R; Pérez-Ecija A; Martínez-Moreno FJ; Martínez-Galisteo E; Moreno T; Pérez J; Martínez-Moreno A
    Parasitol Int; 2010 Jun; 59(2):147-53. PubMed ID: 20035898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The addition of a new immunomodulator with the adjuvant adaptation ADAD system using fatty acid binding proteins increases the protection against Fasciola hepatica.
    López-Abán J; Nogal-Ruiz JJ; Vicente B; Morrondo P; Diez-Baños P; Hillyer GV; Martínez-Fernández AR; Feliciano AS; Muro A
    Vet Parasitol; 2008 May; 153(1-2):176-81. PubMed ID: 18308471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immune responses of cattle to experimental anti-Fasciola hepatica vaccines.
    Mulcahy G; O'Connor F; Clery D; Hogan SF; Dowd AJ; Andrews SJ; Dalton JP
    Res Vet Sci; 1999 Aug; 67(1):27-33. PubMed ID: 10425237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The serum glucose and beta-hydroxybutyrate levels in sheep with experimental Fasciola hepatica and Fasciola gigantica infection.
    Phiri IK; Phiri AM; Harrison LJ
    Vet Parasitol; 2007 Feb; 143(3-4):287-93. PubMed ID: 17011709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attempted immunisation of sheep against Fasciola hepatica using gamma-irradiated metacercariae.
    Creaney J; Spithill TW; Thompson CM; Wilson LR; Sandeman RM; Parsons JC
    Int J Parasitol; 1995 Jul; 25(7):853-6. PubMed ID: 7558572
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MM3-ELISA evaluation of coproantigen release and serum antibody production in sheep experimentally infected with Fasciola hepatica and F. gigantica.
    Valero MA; Ubeira FM; Khoubbane M; Artigas P; Muiño L; Mezo M; Pérez-Crespo I; Periago MV; Mas-Coma S
    Vet Parasitol; 2009 Jan; 159(1):77-81. PubMed ID: 19019548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-resistance between Schistosoma mansoni and Fasciola hepatica in sheep.
    Haroun EM; Hillyer GV
    J Parasitol; 1988 Oct; 74(5):790-5. PubMed ID: 3138395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin L proteinases as vaccines against infection with Fasciola hepatica (liver fluke) in ruminants.
    Mulcahy G; Dalton JP
    Res Vet Sci; 2001 Feb; 70(1):83-6. PubMed ID: 11170858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with cathepsin L phage-exposed mimotopes, single or in combination, reduce size, fluke burden, egg production and viability in sheep experimentally infected with Fasciola hepatica.
    Villa-Mancera A; Alcalá-Canto Y; Reynoso-Palomar A; Olmedo-Juárez A; Olivares-Pérez J
    Parasitol Int; 2021 Aug; 83():102355. PubMed ID: 33872793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 2.9 kDa Fasciola hepatica-recombinant protein based ELISA test for the detection of current-ovine fasciolosis trickle infected.
    Arias M; Hillyer GV; Sánchez-Andrade R; Suárez JL; Pedreira J; Lomba C; Díaz P; Morrondo P; Díez-Baños P; Paz-Silva A
    Vet Parasitol; 2006 Apr; 137(1-2):67-73. PubMed ID: 16417971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of a recombinant Schistosoma bovis-derived glutathione S-transferase to protect cattle against experimental Fasciola hepatica infection.
    De Bont J; Claerebout E; Riveau G; Schacht AM; Smets K; Conder G; Brake DA; Capron A; Vercruysse J
    Vet Parasitol; 2003 Apr; 113(2):135-44. PubMed ID: 12695038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative efficacy of closantel and triclabendazole against Fasciola hepatica in experimentally infected sheep.
    Maes L; Vanparijs O; Lauwers H; Deckers W
    Vet Rec; 1990 Nov; 127(18):450-2. PubMed ID: 2275080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Fasciola hepatica recombinant 15-kDa fatty acid-binding protein T-cell epitopes that protect against experimental fascioliasis in rabbits and mice.
    Muro A; Casanueva P; López-Abán J; Ramajo V; Martínez-Fernández AR; Hillyer GV
    J Parasitol; 2007 Aug; 93(4):817-23. PubMed ID: 17918360
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.